Indianapolis, IN, United States of America

Myron C Rapkin

This inventor holds 56 USPTO granted patents and 11 published patent applications and 11 EPO patents, primarily in Medical Devices (CPC class A61K). Top assignees: Pop Test LLC, Pop Test Abuse Deterrent Technology LLC, Pop Test Oncology, LLC. Active years: 1993-2025.

USPTO Granted Patents = 56 (Patent Applications = 11)

% Patents Active = 66.1

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 4.3

ph-index = 10

Forward Citations = 456(Granted Patents)

Forward Citations (Not Self Cited) = 359(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

Pop Test Abuse Deterrent Technology LLC

patents

10 out of 10

Pop Test Oncology, LLC

patents

4. 9 out of 9

Pop Test Oncology Limited Liability Company

patents

5. 3 out of 1,164

Boehringer Mannheim Gmbh

patents

6. 3 out of 4

Pop Test Cortisol LLC

patents

7. 3 out of 248

Stokely-Van Camp, Inc.

patents

8. 2 out of 4

Taylor Technologies, Inc.

10. 4 out of 834,411

Other

patents

Years Active: 1993-2025

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Medical Devices

Drug Delivery

Wireless Communication

Therapeutic Agents

Bodily Fluids Monitoring

Intradermal Applicator

Diagnosis and Treatment

Sensor Placement

Fluorescence Detection

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12263178 - Pharmaceutical compositions and methods (2025-04-01),

2. 12227727 - Medical devices and uses thereof (2025-02-18),

3. 12205696 - Drug device configured for wireless communication (2025-01-21),

4. 11702443 - Therapeutic agents and methods (2023-07-18),

5. 11576921 - Pharmaceutical compositions and methods (2023-02-14),

6. 11527315 - Drug device configured for wireless communication (2022-12-13),

7. 11364252 - System and method for diagnosis and treatment (2022-06-21),

8. 11224599 - Therapeutic agents and methods (2022-01-18),

9. 11116775 - System and method for diagnosis and treatment (2021-09-14),

10. 11040037 - Therapeutic agents and methods (2021-06-22),

11. 10653447 - Method of using an intradermal applicator for delivering a sensor within the skin (2020-05-19),

12. 10625063 - Drug device configured for wireless communication (2020-04-21),

13. 10537586 - System and method for diagnosis and treatment (2020-01-21),

14. 10517881 - Pharmaceutical compositions and methods (2019-12-31),

15. 10441762 - Drug device configured for wireless communication (2019-10-15),

Title: Unveiling the Innovative Mind of Myron C Rapkin

Introduction:

Myron C Rapkin, a prolific inventor hailing from Indianapolis, IN (US), has left an indelible mark in the field of biotechnology with his groundbreaking contributions. With an impressive portfolio of 53 patents, Rapkin continues to push the boundaries of therapeutic advancements.

Latest Patents:

Among his recent patents, Rapkin has delved into the realm of therapeutic agents and methods. One notable invention includes glucocorticoid receptor antagonists for the treatment of infection, neoplasia, and fatty liver disease. Additionally, his pharmaceutical compositions and methods involving cortisol blockers show promise in tackling viral infections, treatment-resistant prostate cancer, neoplasia, and infection related to acute or chronic injury or disease.

Career Highlights:

Throughout his illustrious career, Rapkin has made significant strides in the biotech industry. Having worked with esteemed companies such as Pop Test LLC and Pop Test Oncology Limited Liability Company, his expertise and innovative spirit have propelled advancements in healthcare and pharmaceuticals.

Collaborations:

In his journey of innovation, Rapkin has collaborated with esteemed professionals including Randice Lisa Altschul and Rebecca O'Brien. Together, they have synergized their expertise to drive forward novel solutions and advancements in the medical field.

Conclusion:

Myron C Rapkin stands as a beacon of innovation, consistently pushing the boundaries of what is deemed possible in the realm of therapeutic treatments. His relentless pursuit of scientific excellence and commitment to improving healthcare reaffirm his position as a trailblazer in the world of biotechnology.